#USA #Select Medical #Mechanicsburg #Cash Dividend #SEM

Select Medical Holdings Corporation: Q3 2025 Results Overview

Mechanicsburg, PA - October 30, 2025
Select Medical Holdings Corporation (NYSE: SEM) recently announced its earnings for the third quarter ending September 30, 2025. The company witnessed a notable revenue increase, reflecting strong operational performance.

Financial Highlights

• - Revenue Growth: The revenue for Q3 2025 rose to $1.363 billion, representing a 7.2% increase compared to $1.272 billion in the same period last year.
• - Income Analysis: Income from continuing operations before other income and expenses surged 32.9%, amounting to $73 million. Meanwhile, the net income from continuing operations, after tax, grew by 7.0% to $44.2 million.
• - Earnings Per Share: Earnings per share for continuing operations also saw an increase of 21.1% to $0.23 compared to $0.19 from the previous year.

Year-to-Date Figures

For the nine-month period ending September 30, 2025:

• - Total revenue reached $4.056 billion, marking a 4.7% increase year-over-year.
• - The income from continuing operations before other income and expense improved by 10.1% to $272.2 million.
• - Adjusted EBITDA was $388.5 million, with earnings per share climbing 44.9% to $1.00.

Critical Segments Performance

1. Critical Illness Recovery Hospitals:
- Revenue increased by 4.6%, reaching $609.9 million. Adjusted EBITDA for this segment rose 10.5% to $56.1 million.
- The adjusted EBITDA margin improved to 9.2%.

2. Rehabilitation Hospitals:
- Revenue expanded by 16.2% to $328.6 million, with an EBITDA increase of 13% to $68 million.
- Adjusted EBITDA margin for this segment stands at 20.7%.

3. Outpatient Rehabilitation:
- This segment recorded a revenue rise of 4.3% to $325.4 million, although adjusted EBITDA experienced a minor decline to $24.2 million.
- Adjusted EBITDA margin decreased to 7.4%.

Dividend Announcement

Select Medical's Board of Directors has declared a cash dividend of $0.0625 per share, which is scheduled for payment on November 25, 2025, to stockholders on record as of November 12, 2025. The company indicated that future dividends will be at the discretion of the Board, contingent on various financial factors.

Stock Repurchase Program

On the corporate front, Select Medical's Board has authorized a stock repurchase program amounting to $1 billion, extending its initial timeline to December 31, 2027. In the nine months leading up to September 30, 2025, the company repurchased 6,375,512 shares at a cost averaging $15.13 per share.

Looking Forward

Select Medical has increased its business outlook for the fiscal year 2025, anticipating revenues between $5.3 billion to $5.5 billion and adjusted EBITDA within the range of $510 million to $530 million. The conference call to discuss these results will take place on October 31, 2025.

Company Overview

As one of the largest operators of acute care and rehabilitation facilities in the U.S., Select Medical continues to focus on providing exceptional care through its various hospital segments, consisting of critical illness recovery hospitals and outpatient rehabilitation clinics.

For more details, visit Select Medical's official website.